AsttraZeneca Pharmaceuticals LP: Drug Recall
Recall #D-0444-2025 · 05/14/2025
Class II: Risk
Recall Details
- Recall Number
- D-0444-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- AsttraZeneca Pharmaceuticals LP
- Status
- Ongoing
- Date Initiated
- 05/14/2025
- Location
- Wilmington, DE, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 807,837 canisters; b) 235,698 canisters
Reason for Recall
Defective delivery system
Product Description
Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .
Distribution Pattern
USA Nationwide
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.